乳腺癌MR动态增强扫描定量分析及其临床应用
被引量:9
Quantitative dynamic contrast-enhanced MRI : clinical application in breast cancer
摘要
对于乳腺癌的检出,乳腺MR成像被认为是一种具有高敏感性和较高特异性的检查方式。动态增强MRI定量分析可以通过Ktrans、kep、ve等多种参数的应用,量化评价肿瘤组织的血管内皮通透性和血流量。其较半定量分析能更为准确、客观地诊断肿瘤的良恶性及评价治疗疗效。就应用动态增强MRI定量分析乳腺癌的现状及目前所存在的问题作一综述。
出处
《国际医学放射学杂志》
2012年第3期240-243,共4页
International Journal of Medical Radiology
参考文献31
-
1Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer [J ]. Radiology,2004, 233: 830-849.
-
2Liberman L. Breast cancer screening with MRI--what are the data for patients at'high risk [J ]. N Engl J Med,2004, 351: 497-500.
-
3Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium [J ]. J Magn Reson Imaging,1999, 10: 903-907.
-
4Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model [J]. Magn Reson Med,1995, 33: 564-568.
-
5Schneider BP, Miller KD. Angiogenesis of breast cancer [J ]. J Clin Oncol, 2005, 23: 1782-1790.
-
6Cron GO, Kelcz F, Santyr GE. Improvement in breast lesion characterization with dynamic contrast-enhanced MRI using pharmacokinetic modeling and bookend T~ measurements [J ]. Magn Reson Med,2004, 51: 1066-1070.
-
7Moon M, Cornfeld D, Weinreb J. Dynamic contrast-enhanced breast MR imaging[J]. Magn Reson Imaging Clin N Am, 2009, 17: 351- 362.
-
8Fritz-Hansen T, Rostrup E, Larsson HB, et al. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging [J ]. Magn Reson Med, 1996, 36: 225- 231.
-
9Simpson NE, Evelhoch JL. Deuterium NMR tissue perfusion measu- rements using the tracer uptake approach: lI . Comparison with mierospheres in tumors [J ]. Magn Resoo Med, 1999, 42: 240-247.
-
10T Simpson NE, He Z, Evelhoch JL. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: I. Optimization of methods [J ]. Magn Reson Med,1999, 42: 42-52.
二级参考文献14
-
1张嵘,李勇,任俊杰,梁碧玲,文艳玲,李海刚.乳腺叶状瘤的影像诊断[J].中华放射学杂志,2004,38(7):717-720. 被引量:23
-
2Sinha S,Sinha U.Recent advances in breast MRI and MRS.NMB Biomed,2009,22:3-16.
-
3Murase K.Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging.Magn Reson Med,2004,51:858-862.
-
4Yankeelov TE,Lepage M,Chakravarthy A,et al.Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer:initial results.Magn Reson Imaging,2007,25:1-13.
-
5Tofts PS,Brix G,Buckley DL,et al.Estimating kinetic parameters from dynamic contrast-enhanced T1 -weighted MRI of a diffusable tracer:standardized quantities and symbols.J Magn Rein Imaging,1999,10:223-232.
-
6Tavassoli FA,Devillee P.WHO classification of tumours pathology & genetics:tumours of the breast and female genital organs.Lyon:IARC Press,2003:9-112.
-
7Huang W,Li X,Morris EA,et al.The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo.Proc Natl Acad Sci USA,2008,105:17943-17948.
-
8Barrett T,Brechbiel M,Bernardo M,et aL MRI of tumor angiogenesis.J Magn Reson Imaging,2007,26:235-249.
-
9Toffs PS.Modeling tracer kinetics in dynamic Gd-DTPA MR imaging J Magn Reson Imaging,1997,7:91-101.
-
10Wang Y,Huang W,Panicek DM.Feasibility of using limitedpopulation-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data.Magn Reson Med,2008,59:1183-1189.
共引文献82
-
1刘骏,钱银锋,朱娟,汪飞,杨擎,张泳.3D-pCASL与DCE-MRI对鼻咽癌灌注相关性研究[J].临床放射学杂志,2020,39(3):466-471. 被引量:9
-
2史红媛,孟庆欣,卢光明.动态增强磁共振成像评价肿瘤血管新生[J].临床放射学杂志,2011,30(10):1553-1556. 被引量:5
-
3史红媛,田迎,罗松,王守巨,朱飞鹏,金利新,王建东,卢光明.动态增强MRI、扩散加权成像及光学成像联合监测抗血管生成治疗后肿瘤反应的动物实验研究[J].中华放射学杂志,2012,46(3):269-274. 被引量:22
-
4纪寒翔,杜青木,于秀艳,吴建锋.动态增强MRI在乳腺肿瘤检查中的诊断价值及应用研究[J].中国妇幼保健,2013,28(11):1738-1740. 被引量:4
-
5林奈尔,柴伟明,华佳.定量动态增强MRI在乳腺癌中的研究进展[J].国际医学放射学杂志,2013,36(4):336-339. 被引量:15
-
6赵莉芸,张仁知,周纯武,李静,王琳.动态增强MR定量分析早期预测乳腺癌新辅助化疗疗效的研究[J].中华放射学杂志,2013,47(8):704-708. 被引量:14
-
7王大伟,马振申,张成琪.乳腺肿瘤MR灌注加权成像的研究进展[J].医学影像学杂志,2013,23(9):1479-1481. 被引量:4
-
8马振申,王大伟,孙秀彬,史浩,庞涛,董桂青,张成琪.3.0T磁共振对乳腺良恶性病变的定量分析[J].山东大学学报(医学版),2013,51(9):79-83. 被引量:8
-
9王世威,许茂盛,丁雪委,葛敏,丁虹,王浩宇.3.0T MRI定量动态对比增强对乳腺疾病的应用价值研究[J].医学影像学杂志,2013,23(10):1558-1561. 被引量:9
-
10杨蕊梦,邹永,罗良平,黄丹萍,徐向东,常汉征,魏新华,伍丽琼,唐文洁,王黎,江新青.动态增强MRI定量监测血管阻断剂治疗兔VX2种植性肝癌的效果[J].中国医学影像技术,2013,29(11):1786-1790. 被引量:2
同被引文献76
-
1顾雅佳,冯晓源,唐峰,彭卫军,毛健,杨文涛.乳腺肿瘤的MRI扩散特征及参数选定[J].中华放射学杂志,2007,41(5):451-456. 被引量:45
-
2El Khouli RH, Macura KJ, Kamel IR, et al. 3-T dynamic con-trast-enhanced MRI of the breast: Pharmacokinetic parametersversus conventional kinetic curve analysis. AJR Am J Roentgen-ol, 2011,197(.6):1498-1505.
-
3Yu Y, Jiang Q, Miao Y, et al. , Quantitative analysis of clinicaldynamic contrast-enhanced MR imaging for evaluating treatmentresponse in human breast cancer. Radiology, 2010,257 (1) : 47-55.
-
4徐慧,贾文霄,周梅.三阴性乳腺癌MR征象与病理学表现的相关性分析.中国医学影像技术,2010,26(增刊):31-34.
-
5Lee SH, Cho N, Kim SJ, et al. Correlation between high resolu-tion dynamic MR features and prognostic factors in breast cancer.Korean J Radiol, 2008,9(1) :10-18.
-
6Tofts PS, BrixG,Buckley DL, et al. Estimating kinetic parame-ters from dynamic contrast-enhanced T(l)-weighted MRI of a dif-fusable tracer: Standardized quantities and symbols. J Magn Re-son Imaging, 1999,10(3) :223-232.
-
7Hammond ME, Hayes DF, Dowsett M, et al. American societyof clinical oncology/college of American pathologists guidelinerecommendations for immunohistochemical testing of estrogen andprogesterone receptors in breast cancer (unabridged version).Arch Pathol Lab Med, 2010,134(7) :e48-e72.
-
8Li SP, Taylor NJ, Makris A, et al. Primary human breast adeno-carcinoma: Imaging and histologic correlates of intrinsic suscepti-bility-weighted MR imaging before and during chemotherapy. Ra-diology, 2010,257(3):643-652.
-
9Pickles MD, Manton DJ, Lowry M, et al. Prognostic value ofpre-treatment DCE-MRI parameters in predicting disease free andoverall survival for breast cancer patients undergoing neoadjuvantchemotherapy. Eur J Radiol, 2009,71(3) :498-505.
-
10Linderholm BK, Heilborg H, Johansson U, et al. Significantlyhigher levels of vascular endothelial growth factor (VEGF) andshorter survival times for patients with primary operable triple-negative breast cancer. Ann Oncol, 2009, 20( 10) : 1639-1646.
引证文献9
-
1赵莉芸,周纯武,张仁知,李静.动态增强MRI定量参数与乳腺癌分子亚型的关系[J].中国医学影像技术,2013,29(7):1126-1130. 被引量:26
-
2王大伟,马振申,张成琪.乳腺肿瘤MR灌注加权成像的研究进展[J].医学影像学杂志,2013,23(9):1479-1481. 被引量:4
-
3王珍,邱晓明,徐潇,罗莉,卢玢,姜兰,王弘.DCE-MRI定量渗透性参数联合ADC值在肺部良恶性病变中鉴别诊断价值[J].磁共振成像,2015,6(8):585-591. 被引量:22
-
4赵勇,罗小虎,李晓峰,王友彬,蒋博.定量动态增强MRI诊断乳腺浸润性导管癌(Ⅱ级)的研究[J].医疗装备,2015,28(18):36-38.
-
5张磊,赵旭,商利明.MR动态增强扫描在上腹部疾病诊断的应用价值分析[J].中外医疗,2016,35(7):165-166. 被引量:4
-
6徐世康,张忠杰.MRI动态增强定量分析技术在乳腺癌新辅助化疗疗效评价中的应用研究[J].河北医学,2016,22(6):892-894. 被引量:8
-
7王珍,胡岗,王松,罗莉,邱晓明.DCE-MRI在肺内良恶性病变的定量化研究[J].临床放射学杂志,2017,36(12):1787-1791. 被引量:9
-
8陈小云.乳腺MRI检查技术及其应用价值[J].泰州职业技术学院学报,2016,16(3):64-66.
-
9李召侠.MR动态增强检查诊断乳腺癌与病理对照分析[J].现代医用影像学,2023,32(2):212-215. 被引量:2
二级引证文献73
-
1郑立球.MR动态增强扫描在上腹部疾病诊断中的应用价值研究[J].世界最新医学信息文摘,2020(81):261-262.
-
2王盈盈,常晓丹.乳腺癌DCE-MR表现与生物学预后因子的相关性[J].中国医学创新,2014,11(4):147-149. 被引量:5
-
3林韵,王小燕,韦海明,贺琰,农美芬,康利克,黄向红,沈桂新,杨海舰.乳腺癌超声造影定量分析参数及增强模式与分子分型的关系[J].中国医学影像技术,2014,30(3):406-410. 被引量:8
-
4王盈盈,常晓丹,付娇慧.乳腺浸润性导管癌3.0 T MRI表现与预后因子相关性研究[J].磁共振成像,2014,5(2):132-137. 被引量:21
-
5胡丽霞,朱进,周阳泱,周亚燕,郭轶群,吴明祥,单军,徐坚民,李先明.鼻咽癌动态增强MRI参数与临床病理特征的关系[J].中国医学影像技术,2014,30(4):514-517. 被引量:10
-
6陈晶晶.MR动态增强扫描在上腹部疾病诊断中的应用价值分析[J].现代医用影像学,2018,27(6):1962-1963. 被引量:1
-
7徐晔,张修石,张红霞,李鹏飞,周洋.乳腺癌分子亚型与MRI表现的相关性[J].中国介入影像与治疗学,2014,11(8):497-501. 被引量:6
-
8胡美玉,潘希敏,刘迪敏.乳腺癌的动态增强MRA的特点研究[J].临床医学工程,2014,21(10):1239-1240.
-
9张菁菁.鼻咽癌动态增强MRI参数和临床病理特征的关系解析[J].现代诊断与治疗,2015,26(9):2015-2016. 被引量:1
-
10张辉,柏根基.磁共振扩散加权与灌注成像在乳腺癌肝转移早期疗效评价中的应用进展[J].医学综述,2015,21(20):3753-3756. 被引量:2
-
1张庆芝,闵锐.血管内皮通透性调节机制新进展[J].中国微循环,2009,13(6):585-588. 被引量:5
-
2司徒勋,张剑珲,陶建平,吴艳兰,郑健斌,黎明.高容量血液滤过对脓毒性休克患儿血流动力学及血管内皮通透性的影响[J].中国当代儿科杂志,2015,17(9):956-960. 被引量:7